NEW YORK, NY and JAKARTA, INDONESIA / ACCESSWIRE / December 19, 2019 / Indonesia Energy Corporation Limited (IEC) (NYSE American:INDO), an oil and gas exploration and production company focused on Indonesia, announced that it priced its initial public offering of 1,363,367 ordinary shares at a price per share of $11.00, for gross proceeds of $15,000,000.

IEC's ordinary shares will be listed on The NYSE American LLC Exchange and are expected to trade beginning on December 19, 2019 under the ticker symbol "INDO". The offering is expected to close on December 23, 2019, subject to customary conditions.

Aegis Capital Corp. is acting as sole bookrunning manager for the offering. IEC has granted the underwriter a 45-day option to purchase up to an additional 204,545 ordinary shares at the initial public offering price to cover over-allotments.

The offering is being made by means of a prospectus. Copies of the prospectus may be obtained, when available, from Aegis Capital Corp., 810 Seventh Avenue, 18th Floor, New York, New York 10019, Attn: Prospectus Department, 810 7th Avenue, 18th floor, New York, NY 10019, by email at syndicate@aegiscap.com or by telephone at (212) 813-1010.

A registration statement relating to these securities has been filed with, and declared effective by, the Securities and Exchange Commission on December 19, 2019. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Cautionary Note Regarding Forward-Looking Statements

This press release contains statements that constitute "forward-looking statements," including with respect to IEC's initial public offering and the underwriter's over-allotment option described herein. Forward-looking statements are subject to numerous conditions, many of which are beyond IEC's control, including those set forth in the Risk Factors section of IEC's registration statement and preliminary prospectus for the offering filed with the Securities and Exchange Commission (SEC). Copies are of such documents are available on the SEC's website, www.sec.gov. IEC undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Contact:
Frank Ingriselli
President, Indonesia Energy Corporation Limited
Frank.Ingriselli@Indo-Energy.com

Public Relations Contact:
MJ Clyburn
TraDigital IR
Phone: +1 (212) 389-9782 x 101
Email: clyburn@tradigitalir.com

SOURCE: Indonesia Energy Corporation Limited 

ReleaseID: 570742

CHARLOTTESVILLE, VA / ACCESSWIRE / December 19, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for addiction, today announced that it has submitted Clinical Trial Applications (CTAs) to commence its first Phase 3 trial in Finland, Estonia, Latvia, Poland, Bulgaria, and Croatia. This follows the Company's recent filing of a CTA to also commence its first Phase 3 trial in Sweden, as previously announced. In total, twenty-six clinical sites in these countries are expected to initially participate in the trial, subject to approval by each country's regulatory authority and ethics committee. The planned Phase 3 trial will test AD04 as a genetically-targeted therapeutic agent for the treatment of Alcohol Use Disorder (AUD).

"Our Phase 3 trial is designed to enroll subjects with selected polymorphisms in the serotonin transporter and receptor genes that are expected to predict those likely to respond to AD04 and to exclude potential subjects that do not have the relevant genetic biomarkers," commented William Stilley, CEO of Adial Pharmaceuticals. "As previously reported, we estimate that the prevalence of people with the targeted genetic biomarkers is about 33% in the United States and greater than 50% in Scandinavia and certain areas of Central and Eastern Europe. The higher expected prevalence of people with the genetic biomarkers in the participating countries should result in faster enrollment and completion as well as reduced trial costs."

About Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions. The Company's lead investigational new drug product, AD04, is a genetically targeted therapeutic agent for the treatment of Alcohol Use Disorder (AUD). A Phase 2b clinical trial of AD04 for the treatment of AUD showed promising results in reducing frequency of drinking, quantity of drinking and heavy drinking (all with statistical significance), and no overt safety concerns (there were no statistically significant serious adverse events reported). The Company plans to commence a Phase 3 clinical trial using AD04 for the potential treatment of AUD in subjects with certain target genotypes, which are to be identified using the Company's proprietary companion diagnostic genetic test. AD04 is also believed to have the potential to treat other addictive disorders such as opioid use disorder, gambling, and obesity. www.adialpharma.com

Forward Looking Statements

This communication contains certain "forward-looking statements" within the meaning of the U.S. federal securities laws. Such statements are based upon various facts and derived utilizing numerous important assumptions and are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Statements preceded by, followed by or that otherwise include the words "believes," "expects," "anticipates," "intends," "projects," "estimates," "plans" and similar expressions or future or conditional verbs such as "will," "should," "would," "may" and "could" are generally forward-looking in nature and not historical facts, although not all forward-looking statements include the foregoing. The forward-looking statements include statements regarding commencing our Phase 3 trial in Finland, Sweden, Estonia, Latvia, Poland, Bulgaria, and Croatia with twenty-six clinical sites being expected to initially participate in the study, the prevalence of the targeted genotype for AD04 being much higher in Scandinavia and certain parts of Central and Eastern Europe resulting in faster enrollment and completion of the trial, as well as reduced study costs, the potential of AD04 to treat AUD and other addictive disorders such as opioid use disorder, gambling, and obesity. Any forward-looking statements included herein reflect our current views, and they involve certain risks and uncertainties, including, among others, the ability to commence the Phase 3 clinical trials as expected in Europe, the ability to achieve faster enrollment and completion of the trial, as well as reduced study costs based on the prevalence of the targeted genotype for AD04 being much higher in Scandinavia and certain parts of Central and Eastern Europe, the ability to capitalize on the market opportunity for AUD, the ability to expand the use of AD04 for use in patients with opioid use disorder, gambling and obesity, the ability of AD04 therapy to perform as designed, to demonstrate safety and efficacy, as well as results that are consistent with prior results, the ability to enroll patients and complete the clinical trials on time and achieve desired results and benefits, our ability to obtain regulatory approvals for commercialization of product candidates or to comply with ongoing regulatory requirements, regulatory limitations relating to our ability to promote or commercialize our product candidates for specific indications, acceptance of its product candidates in the marketplace and the successful development, marketing or sale of products, our ability to maintain our license agreements, the continued maintenance and growth of our patent estate, our ability to establish and maintain collaborations, our ability to obtain or maintain the capital or grants necessary to fund its research and development activities, and our ability to retain our key employees or maintain our Nasdaq listing. These risks should not be construed as exhaustive and should be read together with the other cautionary statement included in our Annual Report on Form 10-K for the year ended December 31, 2018, subsequent Quarterly Reports on Form 10-Q and Current reports on Form 8-K filed with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it was initially made. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, changed circumstances or otherwise, unless required by law.

Contact:

Crescendo Communications, LLC
David Waldman / Natalya Rudman
Tel: 212-671-1021
Email: dwaldman@crescendo-ir.com

SOURCE: Adial Pharmaceuticals, Inc.

ReleaseID: 570773

NEW YORK, NY / ACCESSWIRE / December 19, 2019 / Bernstein Liebhard, a nationally acclaimed investor rights law firm, is investigating potential securities fraud claims on behalf of shareholders of Allakos Inc. ("Allakos" or the "Company") (NASDAQ:ALLK) from allegations that Allakos might have issued misleading information to the investing public.

If you purchased Allakos securities, and/or would like to discuss your legal rights and options please visit Allakos Shareholder Investigation or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com.

On December 18, 2019, Seligman Research ("Seligman") published a report characterizing Allakos as "A Suspect Biotech with a Phase 2 Farce, Incredulous Trial Investigators, and Warning Signs of Potential Fraud." In addition to many other issues, the Seligman report alleged the Company of having "buried the results for the two AK001 studies it conducted, but our research indicates a debacle."

On this news, Allakos's stock price fell $13.25 per share, or 10%, to close at $119.28 on December 18, 2019.

If you purchased Allakos securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/allakosinc-allk-shareholder-class-action-lawsuit-stock-fraud-233/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com.

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. © 2019 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information

Matthew E. Guarnero
Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
MGuarnero@bernlieb.com

SOURCE: Bernstein Liebhard LLP

ReleaseID: 570728

WALTHAM, MA / ACCESSWIRE / December 19, 2019 / Tecogen Inc. (NASDAQ:TGEN), a clean energy company providing ultra-efficient, clean, natural gas driven on-site power, heating, and cooling equipment, is pleased to announce an order of 26 Inverde e+ cogeneration units with installed capacity of 3.25 MW to a housing development in Toronto, Ontario. The units will ship in the first 2 quarters of 2020, and adds to an existing fleet of 6 units to the same development. The customer intends to enter a 20-year service contract on all units and will ultimately lead to the establishment of an Ontario service center opening in 2020.

"This project has been in development for over a year as the customer evaluated different cogeneration technology options," noted Jeff Glick, Vice President of East Coast Sales at Tecogen. "Ultimately the value of our onboard inverter technology and associated UL and CSA certifications combined with Tecogen's longstanding service capabilities made Tecogen the best solution for this project."

The Inverde e+ cogeneration system includes a proprietary inverter system that allows fast and simple interconnection to most electric utilities. Tecogen has also incorporated the CERTS micro-grid control software which allows the unit to integrate other distributed generation assets such as battery storage, and the ability to function independently from the utility during grid outages. The Inverde e+ has UL2200, UL1741SA, CSA C22.2#100 and CSA C22.2#107 certifications, which are required by most utilities in Canada and the United States to support grid services such as demand reduction, VAR support, and frequency response. All units will be equipped with Tecogen's proprietary Ultera emissions technology, which reduces criteria emissions to levels on par with fuel cell technology.

"This order adds to an existing Tecogen fleet in Ontario of 13 cogeneration systems and 4 chillers," stated Joseph E. Gehret, Director of Field Operations at Tecogen. "To provide this customer with the best factory service, a dedicated factory service center located in the Toronto area will be established in early 2020 that will allow Tecogen to commission and maintain the Inverde fleet as units come online later in the year. We are excited by the prospect of what will be our 11th service center in North America and expect this capability to attract additional projects in this growing territory."

"We are very excited about this project and the establishment of our 11th service center," said Benjamin Locke, Tecogen CEO, adding that "Tecogen's unique technology meets the customer's critical needs including that of grid interconnect, efficiency, certifications, and most importantly, factory service. Our factory's ability to fulfill this large order within the strict timelines for the customer aided in the sale. The 20-year maintenance agreement allows us the ability to establish a new service center in the area in early 2020. This service center will also allow additional projects to be identified and supported locally, an important criteria for customers that understand the need for local factory service."

About Tecogen
Tecogen Inc. designs, manufactures, sells, installs, and maintains high efficiency, ultra-clean, cogeneration products including natural gas engine-driven combined heat and power, air conditioning systems, and high-efficiency water heaters for residential, commercial, recreational and industrial use. The company provides cost efficient, environmentally friendly and reliable products for energy production that, through patented technology, nearly eliminate criteria pollutants and significantly reduce a customer's carbon footprint.

In business for over 35 years, Tecogen has shipped more than 3,000 units, supported by an established network of engineering, sales, and service personnel across the United States. For more information, please visit www.tecogen.com or contact us for a free Site Assessment.

Tecogen, InVerde e+, Ilios, Tecochill, Tecofrost, Tecopower, and Ultera are registered or pending trademarks of Tecogen Inc.

Forward Looking Statements
This press release contains "forward-looking statements" which may describe strategies, goals, outlooks or other non-historical matters, or projected revenues, income, returns or other financial measures that may include words such as "believe," "expect," "anticipate," "intend," "plan," "estimate," "project," "target," "potential," "will," "should," "could," "likely," or "may" and similar expressions intended to identify forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to update or revise any forward-looking statements.

In addition to those factors described in our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q under "Risk Factors," among the factors that could cause actual results to differ materially from past and projected future results are the following: fluctuations in demand for our products and services, competing technological developments, issues relating to research and development, the availability of incentives, rebates, and tax benefits relating to our products and services, changes in the regulatory environment relating to our products and services, integration of acquired business operations, and the ability to obtain financing on favorable terms to fund existing operations and anticipated growth.

Tecogen Media & Investor Relations Contact Information:

Benjamin Locke, CEO

P: (781) 466-6402

E: Benjamin.Locke@Tecogen.com

SOURCE: Tecogen, Inc.

ReleaseID: 570772

COTTONWOOD HEIGHTS, UT / ACCESSWIRE / December 19, 2019 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer and provider of athletic training, physical therapy, and rehabilitation products, today announced the appointment of Jennifer Keeler as General Counsel and Ed Staten as Senior Director of Sales Operations. Both positions report to Brian Baker, President and CEO of Dynatronics.

Keeler joins Dynatronics with over 20 years of experience as General Counsel, most recently for Land O'Lakes, a Fortune 200 company. During her career, she has gained significant expertise in contract negotiations, mergers and acquisitions, intellectual property protection, cross-functional advising, and compliance. As General Counsel, Keeler will be a key member of the executive team as Dynatronics continues to pursue its growth initiatives.

Staten joins Dynatronics with over 15 years of experience in sales management, most recently for 3M Healthcare where he was Sales Operations Director in its Medical Solutions Division. In addition to his tenure at 3M Healthcare, Staten has experience with KCI (Acelity), St. Jude Medical, and Depuy/J&J. As Senior Director of Sales Operations, Staten will strengthen the selling organization and position Dynatronics for growth.

"Both Jennifer and Ed bring significant capabilities to Dynatronics," commented Baker. "Jennifer brings a wealth of legal experience and management expertise that will be extremely valuable as we continue to build a scalable platform on which to execute on our strategy. Ed brings years of sales operations experience that will strengthen our selling organization and enhance our ability to fortify customer relationships and increase market share."

About Dynatronics Corporation

Dynatronics is a leading medical device company committed to providing high-quality restorative products designed to accelerate achieving optimal health. The company designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and consumers. The company products are marketed under a portfolio of high-quality, well-known industry brands including Bird & Cronin®, Dynatron Solaris®, Hausmann™, Physician's Choice®, and PROTEAM™, among others. More information is available at www.dynatronics.com.

Contact:

Dynatronics Corporation
Investor Relations
Jim Ogilvie
(801) 727-1755
jim.ogilvie@dynatronics.com

For additional information, please visit: www.dynatronics.com
Like Dynatronics on Facebook
Connect with Dynatronics on LinkedIn
Follow us on Twitter

SOURCE: Dynatronics Corporation

ReleaseID: 570732

SmartSuite IOT, Cloud and Software as a Service

TORONTO, ON / ACCESSWIRE / December 19, 2019 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) ("Kontrol" or 'Company') a leader in the energy efficiency sector through IoT, Cloud and SaaS technology announces that it is launching its new energy technology for the commercial, multi-residential, hospitality and industrial building market.

The SmartSuite solution has been in development for the past 2 years and is now certified for the Canadian market. As part of the launch Kontrol is entering into pilots with three leading commercial real estate management companies. Under the terms of the pilots Kontrol will install its SmartSuite hardware and software in three buildings for a period of 60 days.

Combining leading energy management in real-time with rich cloud analytics and smart learning algorithms, the SmartSuite technology is much more than a traditional smart thermostat.

"Our technology delivers energy savings in real-time by automating up to 80% of heating and cooling controls and provides instant analysis and feedback through our proprietary cloud solution," says Kristian Lavereau, COO of Kontrol Energy. "Our plan is to deliver our technology on a Software as a Service (SaaS) basis allowing our customers the opportunity to avoid large capital expenditures and benefit from immediate energy savings."

According to the EIA, North American buildings consume approximately $200 Billion USD in energy annually and up to 30% of that energy consumption is lost due to inefficiencies. Kontrol's technology addresses that challenge by providing real-time energy savings through enhanced automation, smart learning algorithms and rich analytics in the cloud.

"For the first time real estate managers and owners will be able to assess their best performing building and best performing suites across their entire portfolio in real-time," continues Mr. Lavereau. "Delivering our technology through a SaaS model provides us with a unique market opportunity."

Concurrent with the pilots in Canada, Kontrol is in various non-binding negotiations to begin pilots in the USA and is also in the process of achieving the required certifications for key USA markets. An update on the pilots will be provided in Q1, 2020 as well an update on progress of expanding into the USA.

About Kontrol Energy

Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.

Kontrol Energy is one of Canada's fastest growing companies in 2018 and 2019 as ranked by Canadian Business and Maclean's.

Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com

For further information, contact:

Paul Ghezzi, Chief Executive Officer
paul@kontrolenergy.com or admin@kontrolenergy.com
Kontrol Energy Corp.,
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
Tel: 905.766.0400, Toll free: 1.844.566.8123

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information

Certain information included in this press release, including information relating to future financial or operating performance and other statements that express the expectations of management or estimates of future performance constitute "forward-looking statements". Such forward-looking statements include, without limitation, statements regarding the launch of new energy technology for the commercial, multi-residential hospitality and industrial building market possible future acquisitions and/or investments in operating businesses and/or technologies, accelerated organic growth, , expansion of smart energy technologies into US markets, strategic partnerships to expand into North American Markets, acceleration of recurring SaaS revenues, the provision of solutions to customers and Greenhouse Gas emissions reductions, proposed financial savings and sustainable energy benefits and energy monitoring. Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief are based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that suitable businesses and technologies for acquisition and/or investment will be available, that such acquisitions and or investment transactions will be concluded, that sufficient capital will be available to the Company, that technology will be as effective as anticipated, that organic growth will occur, and others. However, forward-looking statements are subject to risks, uncertainties and other factors, which could cause actual results to differ materially from future results expressed, projected or implied by such forward-looking statements. Such risks include, but are not limited to, lack of acquisition and investment opportunities or that such opportunities may not be concluded on reasonable terms, or at all, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected that customers and potential customers will not be as accepting of the Company's product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and the Company does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise, except as required under applicable securities law.

SOURCE: Kontrol Energy Corp.

ReleaseID: 570752

Combined with expectations for continued share repurchases, dividend program reaffirms Company commitment to returning shareholder value

SAN RAMON, CA / ACCESSWIRE / December 19, 2019 / ARC Document Solutions, Inc. (NYSE:ARC) announced today that it is launching a cash dividend program. The program will operate independently of ARC's current share repurchases in the open market and reaffirms the Company's commitment to returning shareholder value as discussed on ARC's third quarter conference call on November 6, 2019.

At its most recent meeting, the Company's Board of Directors authorized an initial annual cash dividend of four cents per share, payable quarterly. The first quarterly dividend of one cent is payable February 28, 2020 to the Company's shareholders of record on January 31, 2020.

"Using ARC's strong cash flows to aggressively pay down our bank debt has provided the company with outstanding flexibility during this time of transition," said Suri Suriyakumar, CEO of ARC. "Given that our debt ratios are healthy we think it is time for us to embark on a dividend program that will directly benefit our shareholders, especially considering the current market conditions in our industry and our recent stock performance. We are happy to shift our capital allocation strategy to a return of shareholder value via a dividend program and expectations for continued purchases of our own stock in the open market given the current strength of cash flows in the business."

Concurrent with this announcement, ARC also disclosed that it entered into an amendment to its credit facility. In connection with the amendment, the term loan portion of ARC's credit facility was prepaid in full using additional borrowings under the revolving loan portion of its credit facility, which was increased to $80 million. The revolving loan has no regularly scheduled required principal payments. Subject to compliance with its financial covenants and a minimum liquidity test, the amendment also permits ARC to utilize up to $10 million in any twelve-month period to pay dividends or make share repurchases without having to include such amounts in the calculation of one of its financial covenants.

The details of ARC's amendment to the credit facility are included in today's 8-K filing.

About ARC Document Solutions (NYSE: ARC)

ARC Document Solutions distributes documents and information to facilitate communication for design, engineering and construction professionals, real estate managers and developers, facilities owners, and a variety of similar disciplines. The Company provides cloud and mobile solutions, professional services, and hardware to help its customers around the world reduce costs and increase efficiency, improve information access and control, and communicate faster, easier, and better. Follow ARC at www.e-arc.com.

Forward-Looking Statements

This press release contains forward-looking statements that are based on current opinions, estimates and assumptions of management regarding future events and the future financial performance of the Company. All statements other than statements of historical fact, including, but not limited to, "program that will directly benefit our shareholders," "expectations for continued purchases of our own stock," and any projections regarding the financial performance of the Company, including the generation of its cash flows, could be deemed forward-looking statements. We caution you that such statements are only predictions and are subject to certain risks and uncertainties that could cause actual results to differ materially from those contained in the forward-looking statements. In addition to matters affecting the construction, managed print services, document management or reprographics industries, or the economy generally, factors that could cause actual results to differ from expectations stated in forward-looking statements include, among others, the factors described in the caption entitled "Risk Factors" in Item 1A in ARC Document Solution's Annual Report on Form 10-K for the fiscal year ended December 31, 2018, Quarterly Reports on Form 10-Q, and other periodic filings and prospectuses. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

SOURCE: ARC Document Solutions

ReleaseID: 570721

RALEIGH, NC / ACCESSWIRE / December 19, 2019 / As the leading organization for public relations, communications, and marketing professionals, the North Carolina chapter of the Public Relations Society of America is proud to honor those who have worked to elevate their profession. The highest honor the chapter bestows is the Michael L. Herman Excellence in Mentoring Award.

This year's winner of the Michael L. Herman Award is Kelly Williamson, president of the North American region of APCO Worldwide. Williamson started as an intern in 1999, and over her two decades at APCO founded the Raleigh office and built it into a success. As she rose through the ranks, Williamson prioritized helping others achieve. She is an adjunct professor and board member of the Hussman School of Media and Journalism at The University of North Carolina at Chapel Hill, serves as a mentor, and helped launch the Triangle Women in STEM initiative that supports women with a desire to pursue a career in STEM.

"Great mentorship looks different for everyone. I was lucky to have a mentor who advocated for me; helped me see my potential; and also taught me to be patient when I wasn't ready for the next step," Williamson said. "I'm honored to be able to serve as a mentor to others, whether they're returning to work after having their first baby, as they start their career in communications, or as they reach for new heights of leadership. I'm thankful to NCPRSA for recognizing me with this award and helping myself and others in the chapter continue to live Michael Herman's legacy."

"The Michael L. Herman Award sets a very high bar," said Chris Cowperthwaite, APR, president of NCPRSA. "Recipients achieve a significant level of personal success, but also exhibit a passion for improving the broader PR profession, while helping put others on a path to advance and achieve. Kelly's contributions to the profession are inspiring and we're thrilled to recognize her with the 2019 award."

Prior to his passing in 2015, Michael L. Herman, APR, was inducted into the PRSA College of Fellows and earned the Gold Anvil Award, PRSA's highest individual award lifetime career achievement. Herman served as a mentor for countless PR professionals in North Carolina through his work, as a leader in NCPRSA, and as a faculty member at N.C. State University's School of Communication.

Previous winners of the Michael L. Herman Excellence in Mentoring Award include Raymond J. Hornak, APR (2015), Tracy Phelan Lathan, APR (2016), Chuck Norman, APR (2017), and Valerie Fields (2018).

The following companies are champions of PR, communications, marketing and our NCPRSA chapter.

Presenting Sponsor:

ACCESSWIRE, an Issuer Direct company

Silver Sponsors:

Eckel & Vaughn
PPD

Bronze Sponsors:

Coastal Credit Union
Engage Media Communications
Joseph Gaitens, APR
North Carolina Nurses Association

ABOUT NCPRSA

The Public Relations Society of America is the nation's largest association of public relations professionals and among the world's largest associations of communicators. Its tag line is "Advancing the Profession and the Professional." Since 1967, the North Carolina Chapter has helped set the standard for excellence in all aspects of the profession. NCPRSA provides leadership, counsel, understanding, networking and educational growth opportunities for those within the profession and to those who may need public relations services.

CONTACT:

Corinne Watson
NCPRSA Awards Director
Corinne.n.watson@gmail.com

SOURCE: NCPRSA

ReleaseID: 570714

EL SEGUNDO, CA / ACCESSWIRE / December 19, 2019 / Red Rock Secured is proud to announce that they have been featured in Fortune magazine's 2020 Investors Guide. The Investors Guide is created using information compiled by a roundtable of investing experts to create a comprehensive list of what to look out for each year.

In the 2020 Investors list, Red Rock Secured is the only Gold IRA company that is featured showing their strength within the industry.

"It is an honor to not only be named to the Fortune magazine 2020 Investors Guide but as the only Gold IRA company as well," says Sean Kelly, founder and CEO of Red Rock Secured. "Our team works hard for every one of our clients and our dedication has shown time and again that it provides results. We are dedicated to protecting the retirement accounts of our clients and we work to ensure that they can rest safely knowing their retirement is safe."

Red Rock Secured's two page spread within the Fortune magazine also highlights their upcoming Red Rock 2020 Gold Report. With the upcoming election, it is important to protect your investment portfolios and be ready for what could come next. To get on the early access list for the 2020 Gold Report, visit www.2020goldreport.com.

About Red Rock Secured

Founded after the market crash in 2008, Red Rock Secured was built upon the focus of helping to protect their clients' IRAs, 401Ks, and other qualifying tax deferred retirement accounts by helping them be invested in assets that are never fully depleted such as gold and other precious metals. Built upon their values and integrity, Red Rock Secured prides itself on their success and their customer service. Located in El Segundo, California, Red Rock Secured employs approximately 50 members and affiliates dedicated to protecting your assets.

For more information, or to contact Red Rock Secured, please visit: redrocksecured.com

Contact:
Jeff Ward
Phone: 424-218-0475
Email: jeffw@redrocksecured.com
Website: www.redrocksecured.com

SOURCE: RED ROCK SECURED

ReleaseID: 570771